ProAssurance Acquisition Nears Final Approval as Key Hurdles Cleared

The planned acquisition of ProAssurance by The Doctors Company is advancing toward its anticipated conclusion in the first half of 2026. With overwhelming shareholder support and crucial regulatory milestones now achieved, ProAssurance shares are trading near the all-cash offer price of $25 per share.

A significant step forward occurred on July 7, 2025, when the mandatory waiting period under the Hart-Scott-Rodino Antitrust Improvements Act was terminated ahead of schedule. This development leaves only the requisite approvals from state insurance regulators in relevant jurisdictions as the final administrative step.

The transaction received resounding support from ProAssurance stockholders on June 24, 2025. More than 99% of the votes cast were in favor of the merger agreement. The $25 per share acquisition price represented a substantial premium... Read more...